A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

Published 2010 View Full Article

Authors

Keywords

Journal

ANNALS OF THE RHEUMATIC DISEASES

Volume 70, Issue 5, Pages 747-754

Publisher

BMJ

Online

2010-12-21

DOI

10.1136/ard.2010.134254

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

ANNALS OF THE RHEUMATIC DISEASES

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer